Quality of life in NLPHL patients
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at how people with a rare type of Hodgkin lymphoma (NLPHL) feel about their health and quality of life. By filling out surveys, you can help doctors understand what really matters to patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must be 8 years old or older.
- You or the adult helping you must be able to read and speak English.
- You must have a diagnosis of nodular lymphocyte-predominant Hodgkin lymphoma (a type of slow-growing lymphoma).
- Your lymphoma must not be combined with another type of lymphoma at the time of diagnosis.
- You or your child must be able to fill out electronic quality-of-life surveys on a computer or tablet.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks the experiences of people with follicular lymphoma over time, using online updates from home. It helps researchers understand what it's like to live with this condition and how care can be improved.
This study looks at quality of life in people age 70 and older with slow-growing (low-grade) B-cell non-Hodgkin lymphoma who haven’t been treated yet. It requires a geriatric (aging-focused) check before starting care, to see what helps older patients feel better during treatment.
This study looks at how social and genetic factors affect the health and quality of life of young adults who have survived Hodgkin or non-Hodgkin lymphoma. It may help doctors better support survivors after treatment.
This study asks people with cutaneous lymphoma to fill out a questionnaire about quality of life. The goal is to better understand how this illness affects day-to-day life and comfort.
This study collects health information from people recently diagnosed with lymphoma to learn more about how the disease progresses and how to improve long-term well-being. It does not test a new treatment but helps researchers better understand what affects survival and quality of life.
This study collects blood and tumor tissue samples from people newly diagnosed with aggressive non-Hodgkin lymphoma who will receive standard chemotherapy. The goal is to improve future tests for detecting minimal residual disease (tiny amounts of cancer left after treatment).
Hear when a new Nodular Lymphocyte-Predominant Hodgkin Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.